Skip to main content
Environmental Health and Preventive Medicine logoLink to Environmental Health and Preventive Medicine
. 2003 Mar;8(1):1–5. doi: 10.1007/BF02897936

SST-2 tumor inoculation is a useful model for studying the anti-tumor immune response in SHR rats

Naomi Nishio 1,, Katsutaka Oishi 2, Kazuhiko Machida 1
PMCID: PMC2723258  PMID: 21432108

Abstract

Objective

The purpose of the present study was to investigate the relation between the dose of tumor cell inoculation (especially the doses less than minimum required to evoke tumor growth) and the anti-tumor immune system, particularly lymphoblast formation and cytotoxic activity of lymphcytes.

Method

We inoculated rats with various doses of SST-2 tumor cells and examined natural killer (NK) cell activity and lymphoblast formationin vitro.

Result

The results showed that the cytotoxicities against SST-2 cells and lymphoblast formation of lymphocytes were enhanced by small dose inoculation of tumor cells that could not induce tumor growth.

Conclusion

It was suggested that was lymphocutes play an important role as an anti-tumor immune system at small doses of tumor inoculation, which appears to reflect an early stage of tumor growthin vivo. It was also suggested that SST-2 tumor inoculation might be a useful model for studying the anti-tumor immune response in SHR rats.

Key words: SST-2, SHR rat, tumor inoculation, NK cell, T cell

References

  • (1).Zeze K, Saito T, Kobayashi M. Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients. Nippon Geka Gakkai Zasshi 1989; 90: 22–33. [PubMed]
  • (2).Kawarabayasgu N, Seki S, Jatsuse K, Ohkawa T, Koike Y, Aihara T, Habu Y, Nakagawa R, Ami K, Hiraide H, Mochizuki H. Decrease of CD 56 (+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32: 962–969. [DOI] [PMC free article] [PubMed]
  • (3).Turochko AD, Nagarkatti PS, Elgert KD. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells. Cancer Immunol. Immunother 1989; 30: 170–176. [DOI] [PMC free article] [PubMed]
  • (4).Traversari C, Bruggen van der P, Luescher IF, Lurquin C, Chomez P, Van Pel A, Plaen De E, Amar-Costesec A, Boon T. A nonpeptid encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992; 176: 1453–1457. [DOI] [PMC free article] [PubMed]
  • (5).Karre K, Ljunggren H, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986; 319: 675–678. [DOI] [PubMed]
  • (6).Hosokawa N, Kobayashi H. Allogeneic cell immunity.—Tumor Markers—. In: Busch H, Yeoman LC, editors. Methods in Cancer Res. 20. New York, Academic Press 1982, p. 85–106.
  • (7).Korzeniewski C, Callewaert PM. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 1983; 64: 313–320. [DOI] [PubMed]
  • (8).Konjevic G, Jurisic V, Spuzic I. Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J. Immunol. Methods 1997; 199–200. [DOI] [PubMed]
  • (9).Matsuoka T. Age related changes of immune rreactivities and antittumor effects in spontaneoussly hypertensive rats (SHR) with T-cell depression. Hokkaido Igaku Zasshi 1989; 64: 551–557. [PubMed]
  • (10).Matsuoka T, Takeichi N, Kobayashi H. Age-related changes of natural antitumor resistance in spontaneously hypertensive rats with T-cell depression. Cancer Res. 1987; 47: 3410–3413. [PubMed]
  • (11).Tonaka K, Yoshikawa T, Bieberich C, Jay G. Role of the major histocompatibility complex class 1 antigens in tumor growth and metastasis. Annu. Rev. Immunol. 1988; 6: 359–380. [DOI] [PubMed]
  • (12).Altenschmidt U, Kahl R, Klundt E, Stocklin E, Mihatsch M, Weindel K, Groner B. Schwannnoma cells induced a tumor— cell-specific cytotoxic—T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors. Int. J. Cancer 1997; 70: 542–550. [DOI] [PubMed]
  • (13).Hoglund P, Ohlen C, Carbone E, Franksson L, Ljunggren HG, Latour A, Koller B, Kaarre K. Recognition β2-microglobulin0negative (β2m− T-cell blasts by natural killer cells from normal but not from β2m− mice. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 10332–10336. [DOI] [PMC free article] [PubMed]
  • (14).Welsh Jr RM, Kiessling RW. Natural killer cell response to lymphocytic choriomeningitis virus in beige mice. Scand J. Immunol. 1980; 11: 363–367. [DOI] [PubMed]
  • (15).Wright SC, Bonavida B. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Intergeron-induced inhibition of NK target cell susceptibikity to lysis is due to a defect in their abiliy to stimulate release of natural killer cytotoxic factors (NKCF). J. Immunol. 1983; 130: 2965–2968. [PubMed]

Articles from Environmental Health and Preventive Medicine are provided here courtesy of The Japanese Society for Hygiene

RESOURCES